Status:
WITHDRAWN
Clinical Efficacy of Intense Pulsed Light(IPL) Procedure in Dry Eye Patient
Lead Sponsor:
Samsung Medical Center
Conditions:
Dry Eye Syndromes
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
Clinical efficacy of Intense Pulsed Light(IPL) procedure in dry eye patients with meibomian gland dysfunction prior to cataract surgery.
Detailed Description
IPL procedure is a device used for symptom relief and treatment of dry eye syndrome caused by meibomian gland dysfunction in adults, and its safety and long-term effects have been confirmed. The purpo...
Eligibility Criteria
Inclusion
- A patient at the age of 21 cataract surgery
- A patient has the visual potential of 20/25 or better in each eye after cataract removal
- Dry eye patient by meibomian gland dysfunction
- Written informed consent to surgery and participation in the study
Exclusion
- Eye damage, active eye infection
- Uncontrolled health problem
- Wear contact lens within one month
- Allergic reactions of fluorescein sodium or ophtalmic anesthetic
- Eye surgery and trauma in the last six months
- Eye disease, structural abnormality
- If there is a cause of vision loss other than cataracts
- Under 20/25 expect vision
- Under the age of 20 years of age
- Pregnant woman and lactating woman
- Medical conditions in which IPL is contraindicated
Key Trial Info
Start Date :
March 3 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 2 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04391907
Start Date
March 3 2020
End Date
March 2 2021
Last Update
May 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea